Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
BTC and ETH have different launch timelines and development paths. This intro compares which is newer and what that means for investors and strategies.
20,975 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Want more money back from everyday spending? This guide breaks down the credit cards with the best cash back rewards,...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...
As the labor market tightens, some firms are betting on competitive ping pong to boost retention and recruiting. This...
SpaceX just fell below its IPO price, a moment that sparks questions for every investor. This guide breaks down what ...
President Trump pushes to suspend the federal gas tax to lower pump prices, but analysts say higher oil prices and fu...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Memory chips are fueling a renewed AI stock rally, but Harvard’s Willy Shih cautions that the boom could cool. Here’s...
A recent public appearance pulls attention from royal headlines and redirects it toward the Invictus Games. This shif...
Global oil inventories are near eight-year lows as tensions around Iran raise the risk of supply disruption. Prices h...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Greenboard closes a $15.5 million Series A to scale its AI-driven compliance platform, expanding to more banks and fi...